These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 3274448)
21. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab. Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147 [TBL] [Abstract][Full Text] [Related]
22. Diagnosis of human allograft rejection by flow cytometry using two-color fluorescence and monoclonal antibodies. Cunningham P; Gross U; Matthews C; Thomas J; Silverman J; Thomas F Transplant Proc; 1987 Feb; 19(1 Pt 2):1578-9. PubMed ID: 3274388 [No Abstract] [Full Text] [Related]
23. Two-color flow cytometric techniques as a diagnostic tool for rejection of renal transplantation. Hayashi R; Sakakibara I; Suzuki S; Amemiya H Transplant Proc; 1987 Feb; 19(1 Pt 2):1603-4. PubMed ID: 3152631 [No Abstract] [Full Text] [Related]
24. The evolution and future of immunosuppression in renal transplantation. Goral S; Helderman JH Semin Nephrol; 1997 Jul; 17(4):364-72. PubMed ID: 9241720 [TBL] [Abstract][Full Text] [Related]
25. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection. Lazarovits AI; Rochon J; Banks L; Hollomby DJ; Muirhead N; Jevnikar AM; White MJ; Amlot PL; Beauregard-Zollinger L; Stiller CR Transplant Proc; 1993 Feb; 25(1 Pt 1):820-2. PubMed ID: 7679844 [No Abstract] [Full Text] [Related]
26. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients. van Gelder T; Knoop CJ; Hesse CJ; Vaessen LM; Balk AH; Yzermans JN; Weimar W Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206 [No Abstract] [Full Text] [Related]
27. OKT3-treated kidney transplant patients: monitoring of effects on peripheral blood mononuclear cells by using two-color flow cytometry. Harford AM; Shopp GM; Ashmore LM; Seppelt JE; Mosdell DM; Gibel LJ; Sterling WA Transplant Proc; 1988 Feb; 20(1 Suppl 1):245-8. PubMed ID: 3279615 [No Abstract] [Full Text] [Related]
28. The clinical application of monoclonal antibody therapies in renal transplantation. Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134 [TBL] [Abstract][Full Text] [Related]
29. Polymorphism of Fc receptor (Fc gamma RII) is reflected in cytokine release and adverse effects of mIgG1 anti-CD3/TCR antibody during rejection treatment after renal transplantation. Tax WJ; Frenken LA; Glaudemans CA; Tamboer WP; Koene RA Transplant Proc; 1995 Feb; 27(1):867-8. PubMed ID: 7879211 [No Abstract] [Full Text] [Related]
30. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients. van Gelder T; Mulder AH; Balk AH; Mochtar B; Hesse CJ; Baan CC; Vaessen LM; Weimar W J Heart Lung Transplant; 1995; 14(2):346-50. PubMed ID: 7779855 [TBL] [Abstract][Full Text] [Related]
31. Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance. Taube D; Welsh KI; Bewick M; Dische FE; Palmer A; Parsons V; Snowden S Transplant Proc; 1987 Feb; 19(1 Pt 3):1961-3. PubMed ID: 3274456 [No Abstract] [Full Text] [Related]
32. In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients. Stock PG; Lantz M; Light S; Vincenti F Transplant Proc; 1996 Apr; 28(2):915-6. PubMed ID: 8623460 [No Abstract] [Full Text] [Related]